On August 17th, the FLF hosted our second webinar called “How Close Are We to Curing Follicular Lymphoma?”. We took inspiration from our recent satellite symposium which we hosted at the 17th International Conference on Malignant Lymphoma in June 2023, and wanted to raise this very important topic within the FL community.
Missed the live session? Catch up now!
Dr Mitchell Smith, our Chief Medical Officer at the FLF chaired the live webinar and led an interactive discussion along with Dr Loretta Nastoupil. There was also recorded footage of Ms Nicky Greenhalgh interviewing the two clinicians. See further down for more information on our speakers.
This webinar session answered some of the most burning questions in the FL community, including:
Your input matters
We value your suggestions, feedback, and topic requests for future webinars. If there’s a specific aspect of follicular lymphoma you’d like us to cover, or any other input you’d like to share, please reach out to us. We are committed to continuously improving our webinars based on your needs and interests.
If you’re unsure about any of the terms and treatments discussed, please visit our glossary.
Dr Mitchell Smith – Chief Medical Officer, Follicular Lymphoma Foundation
Dr Mitchell Smith has an extensive educational background, having earned his Medical Degree and PhD from Case Western Reserve University School of Medicine in Cleveland, OH. He has also completed several residencies and fellowships, including a Fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Centre in NY. Dr Smith’s career has also spanned many years and institutions, including serving as Director of the Lymphoma Program at Fox Chase Cancer Centre and Director of the Lymphoid Malignancy Program at the Cleveland Clinic.
Ms Nicky Greenhalgh – Founder of Living with Follicular Lymphoma Facebook group
Nicky was diagnosed with FL in 2014. She commenced treatment immediately and has so far remained NED. Nicky founded the ‘Living with Follicular Lymphoma‘ Facebook community in November 2015 after seeking support and has since found a passion for patient advocacy.
Dr Loretta Nastoupil – Deputy Chair Section Chief, MD Anderson Cancer Center
Loretta J. Nastoupil, MD is an Associate Professor in the Department of Lymphoma/Myeloma at the University of Texas MD Anderson Cancer Center in Houston, TX USA. Dr. Nastoupil completed her internal medicine training at Washington University and hematology/medical oncology fellowship at Emory University. She is currently Deputy Chair of the Lymphoma/Myeloma Department and Section Chief of the indolent lymphoma and new drug development teams which are in line with her research interests of designing and conducting prospective trials aimed at exploiting the immune system to eradicate B-cell lymphoma.
